ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 143

Detailed Anatomical Distribution of Synovial Inflammation Revealed By Ultrasound in Patients with Blau Syndrome

Kei Ikeda1, Naotomo Kambe2, Syuji Takei3,4, Taiji Nakano5, Yuzaburo Inoue5, Minako Tomiita6, Natsuko Oyake7, Takashi Satoh8, Tsuyoshi Yamatou3, Tomohiro Kubota3, Ikuo Okafuji9, Nobuo Kanazawa10, Ryuta Nishikomori11, Naoki Shimojo5, Hiroyuki Matsue8 and Hiroshi Nakajima1, 1Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan, 2Dermatology, Chiba University Graduate School of Medicine, Chiba, Japan, 3Department of Pediatrics, Kagoshima University Hospital, Kagoshima, Japan, 4School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan, 5Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan, 6Department of Allergy and Rheumatology, Chiba Children’s Hospital, Chiba, Japan, 7Department of Pediatrics, Hitachinaka General Hospital, Hitachinaka, Japan, 8Department of Dermatology, Chiba University Graduate School of Medicine, Chiba, Japan, 9Department of Pediatrics, Kobe City Medical Center General Hospital, Kobe, Japan, 10Department of Dermatology, Wakayama Medical University, Wakayama, Japan, 11Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Blau syndrome, Synovitis, Tendonitis/bursitis, tumor necrosis factor (TNF) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose

Arthritis is the most frequent manifestation of Blau syndrome, an autoinflammatory disorder caused by the genetic mutation of NOD2. However, the detailed information on arthritis in Blau syndrome which the therapeutic strategy should be based on was lacking. This multi-center study aimed to accurately characterize the articular manifestation of Blau syndrome and also to demonstrate the utility of musculoskeletal ultrasound in Blau syndrome.

Methods

Patients who had been diagnosed with Blau syndrome by genetic analysis of NOD2 were recruited. A total of 102 synovial sites in 40 joints were assessed semiquantitatively by ultrasound for gray-scale synovitis and synovial power Doppler (PD) signal.

Results

Ten patients whose age ranged from 10 months to 37 years enrolled in this study. Although only four joints (0.8 %) were tender on physical examination, 81 joints (16.9 %) were clinically swollen. Moreover, 240 (50.0 %), and 124 (25.8 %) joints showed GS synovitis and synovial PD signal on ultrasound, respectively. Importantly, GS synovitis was present in 168 out of 399 non-swollen joints, in which 61 also exhibited synovial PD signal. Among 40 joint regions, the ankle, the wrist, and the proximal interphalangeal joints were the most frequently and severely affected joints (Figure). Comparisons between different synovial tissues demonstrated a significantly higher proportion of the joints with tenosynovitis as compared with that with intra-articular synovitis (41.5 % vs. 27.9 %, P < 0.0001). In respect of age and treatment, synovial PD signals were minimal in the youngest patient and in the oldest two patients, and were relatively mild in patients receiving treatment with methotrexate plus TNF antagonists. In two patients who underwent the 2nd ultrasound examination, total PD scores markedly decreased after initiating the treatment with a TNF antagonist.

Conclusion

The detailed information on synovial inflammation obtained by ultrasound confirms the dissociation between pain and inflammation and the frequently involved joint regions and synovial tissue in the arthritis of Blau syndrome. Our data also demonstrate that ultrasonography can be a potent tool in monitoring the activity of synovial inflammation and in investigating the pathophysiology of arthritis in this rare but archetypical autoinflammatory condition.

Figure. Mean gray-scale and power Doppler scores for intra-articular- and teno-synovitis in each joint

Mean ultrasound scores for each joint in 10 patients are shown in color grades. Only 1st ultrasound examinations in Patient 5 and 6 are included.

* Ultrasound scores for tenosynovitis are not applicable in elbows and knees where typical tenosynovium does not exist.


Disclosure:

K. Ikeda,

Mitsubishi-Tanabe Pharma Corporation,

5,

Takeda Pharmaceutical,

5,

Pfizer Japan,

5,

Mitsubishi-Tanabe Pharma Corporation,

2;

N. Kambe,

Mitsubishi-Tanabe Pharma Corporation,

5;

S. Takei,

Mitsubishi-Tanabe Pharma Corporation,

5,

Mitsubishi-Tanabe Pharma Corporation,

2,

Takeda Pharmaceutical,

5,

Takeda Pharmaceutical,

2,

Pfizer Japan,

5;

T. Nakano,
None;

Y. Inoue,
None;

M. Tomiita,
None;

N. Oyake,
None;

T. Satoh,
None;

T. Yamatou,
None;

T. Kubota,

Mitsubishi-Tanabe Pharma Corporation,

5;

I. Okafuji,
None;

N. Kanazawa,

Mitsubishi-Tanabe Pharma Corporation,

5;

R. Nishikomori,

Mitsubishi-Tanabe Pharma Corporation,

5;

N. Shimojo,
None;

H. Matsue,

Mitsubishi-Tanabe Pharma Corporation,

5,

Mitsubishi-Tanabe Pharma Corporation,

2,

Pfizer Japan,

5,

Pfizer Japan,

2;

H. Nakajima,

Mitsubishi-Tanabe Pharma Corporation,

5,

Mitsubishi-Tanabe Pharma Corporation,

2,

Takeda Pharmaceutical,

5,

Takeda Pharmaceutical,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detailed-anatomical-distribution-of-synovial-inflammation-revealed-by-ultrasound-in-patients-with-blau-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology